Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Whyte

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Blood Advances|December 24, 2025
Rapid Detection of Fibrinolytic Activation in Postpartum Hemorrhage and Acute Obstetric Coagulopathy Using a Novel AssayAnton Ilich, Claire S Whyte, Chatphatai Moonla, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Platelet factor XIII-A regulates platelet function and promotes clot retraction and stabilityJoanne L Mitchell, Gemma Little, Alexander P Bye, et al.
BMJ Open|June 5, 2025
Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: study protocol for a phase II clinical trialMarina Frimer, Arielle Katcher, Pegah Blustein, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Blood Advances|December 24, 2025
Rapid Detection of Fibrinolytic Activation in Postpartum Hemorrhage and Acute Obstetric Coagulopathy Using a Novel AssayAnton Ilich, Claire S Whyte, Chatphatai Moonla, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Platelet factor XIII-A regulates platelet function and promotes clot retraction and stabilityJoanne L Mitchell, Gemma Little, Alexander P Bye, et al.
BMJ Open|June 5, 2025
Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: study protocol for a phase II clinical trialMarina Frimer, Arielle Katcher, Pegah Blustein, et al.
Pageof 14